ArticleJournal of gastrointestinal cancer2022

In vivo Study of a Newly Synthesized Chromen-4-one Derivative as an Antitumor Agent against HCC.

Asmaa I Nabeel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.